Impact of the COVID-19 pandemic on the treatment of patients with Stage III unresectable non-small cell lung cancer (NSCLC)
People with unresectable stage III non-small cell lung cancer are asked to participate in a research study being conducted by Montefiore Medical Center.
You may be eligible to participate in this study if you:
• Are a male or female at least 18 years of age
• Have pathological confirmation of NSCLC obtained from a tumor cytology or biopsy
• Have a documented diagnosis of TNM Stage III unresectable NSCLC
You may NOT participate in this study if you:
• Are participating in any clinical trial for the treatment of Stage III unresectable NSCLC
• Have received prior surgery with complete resection
• Have not received treatment for Stage III unresectable NSCLC
Contact Information
Charlotte Sklow, Study Coordinator
1695 Eastchester Road
Bronx, New York 10461
Phone: (718) 405-8535
Email: CHARLOTTE.SKLOW@EINSTEINMED.ORG
21-08-330